ANDA 87226, held by Camall. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 87226 (Phentermine Hydrochloride), held by Camall, was first approved by FDA on Sep 10, 1980, with 12 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 10, 1980 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phentermine Hydrochloride30MG ยท capsule;oral | Phentermine Hydrochloride | Discontinued |
| Nov 3, 1998 | Supplement 20Labeling | Approved | None posted |
| Aug 19, 1998 | Supplement 19Labeling | Approved | None posted |
| Apr 8, 1998 | Supplement 18Labeling | Approved | None posted |
| Dec 19, 1997 | Supplement 17Labeling | Approved | None posted |
| Oct 16, 1992 | Supplement 16Manufacturing | Approved | None posted |
| Sep 12, 1989 | Supplement 14Labeling | Approved | None posted |
| Jun 27, 1988 | Supplement 13Manufacturing | Approved | None posted |
| Jun 27, 1988 | Supplement 12Manufacturing | Approved | None posted |
| Apr 25, 1984 | Supplement 10Manufacturing | Approved | None posted |
| Dec 22, 1983 | Supplement 9Manufacturing | Approved | None posted |
| Dec 22, 1983 | Supplement 8Manufacturing | Approved | None posted |
| Apr 28, 1983 | Supplement 5Manufacturing | Approved | None posted |
| Sep 10, 1980 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters